Conference

Acutis is on it. Our Sales Specialists Stephen Dybalski and Kseniya Shyrokava were on hand at the 2018 New York & New Jersey Societies of Interventional Pain Physicians’ Pain Medicine Symposium

icone-conference-nov8.jpg

The theme of this year’s show “Evolving Advanced Pain Therapies” could not be more relevant in light of the current opioid and pain-management crises. Nor could it be a more appropriate venue for Acutis to share with this community our new definition of care: A company at the leading edge of medical diagnostics. A company committed to ensure professionals in this specialty have one less thing to worry about.

Led by Chairman, Sudhir Diwan, MD, and Course Directors, Scott Woska, MD and Christopher Gharibo, MD. The show provided the most up-to-date information on advanced pain management techniques, pharmacology, neurostimulation, vertebroplasty, kyphoplasty, discography as well as other treatments and procedures.

Both Stephen and Kseniya made a special point to visit with our current pain-management clients who were in attendance, as well as introduce potential clients to Acutis’ expanding capabilities. New contacts were cultivated and, as important, new lessons were learned that will be shared throughout the entire Acutis network.

During the show Stephen and Kseniya became acquainted with those new products and procedures that were most exciting to members of the medical community. Of particular interest were training geared for primary caregivers, as well as medical-management physicians who require specific training in the prescribing and utilization of opioids and controlled substances.

500 specialists in pain and interventional pain management, as well as neurosurgery were in attendance. Acutis is proud to have been among this esteemed company.

Acutis Steps Up at the 19th Annual ASAP Conference

From September 23rd through the 27th 2018,  CEO Jibreel Sarij and Sales Specialists Jared Blais and Emily Talarico attended the Alcoholism and Substance Abuse Providers of New York State (ASAP) Annual Conference in Syracuse, New York. 

ASAP-website.jpg

That we’re in the midst of a crisis is not news. All attendees at the ASAP Conference are acutely aware of the enormity of the problem. Ben Walsh, the Mayor of Syracuse, mentioned in his remarks that a death by an overdose occurred only a few days earlier, a block from the conference center. Everyone, from caseworkers and administrators, to medical practitioners and specialists, had their war stories. There was no shortage of tactics and strategies discussed, all focused on ASAP’s guiding principle that addiction is a treatable and preventable disease.

A highlight of the conference was a talk by the journalist Sam Quinones, author of the National Book Critics Circle Award-winning book, Dreamland: The True Take of America’s Opiate Epidemic. Quinones took on one of the most controversial issues of the day: how heroin moved from the urban centers into our nation’s heartland.

During the event, Jibreel Sarij spoke at length with ASAP’s Executive Director John Coppola, The two discussed how the ASAP might tap into Acutis’ expertise in drug testing and also how the ASAP might benefit from access to vast amounts of data Acutis has compiled. Coppola accepted an invitation to visit our facility.

We look forward to new friends and a dynamic collaboration.

Visit the 19th Annual ASAP Conference website.

Expectations met at ICCO 2018

boston.jpg

Acutis Diagnostics’ Charlie Clark and Chuck Orefice attended the International Conference on Opioids, at the Joseph B. Martin Conference Center at Harvard Medical School in Boston, Massachusetts, held from June 10th - 12th, 2018.

We came with high expectations for this meeting, especially in light of the current crisis. We were not disappointed. Thought leaders and practitioners from the U.S. and abroad addressed topics of increasing urgency, from the best emerging medical practices using opioid to treat pain, to the rapidly evolving ethical and legal aspects of opioid management.

Acutis Diagnostics is intimately familiar with the challenges faced by physicians who seek greater clarity and new competences. Toward that end, we were excited to learn new concepts and applications in medication monitoring and illicit drug testing. We will continue to hone our science and services with a single goal in mind: reduce risk to both practitioners and patients, while improving clinical outcomes.